These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 28325769)
1. Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin. Rajendran M; Nachbagauer R; Ermler ME; Bunduc P; Amanat F; Izikson R; Cox M; Palese P; Eichelberger M; Krammer F mBio; 2017 Mar; 8(2):. PubMed ID: 28325769 [TBL] [Abstract][Full Text] [Related]
2. Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans. Nachbagauer R; Choi A; Izikson R; Cox MM; Palese P; Krammer F mBio; 2016 Jan; 7(1):e01996-15. PubMed ID: 26787832 [TBL] [Abstract][Full Text] [Related]
3. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers. Desheva YA; Smolonogina TA; Donina SA; Rudenko LG BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924 [TBL] [Abstract][Full Text] [Related]
4. Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins. Nachbagauer R; Choi A; Hirsh A; Margine I; Iida S; Barrera A; Ferres M; Albrecht RA; García-Sastre A; Bouvier NM; Ito K; Medina RA; Palese P; Krammer F Nat Immunol; 2017 Apr; 18(4):464-473. PubMed ID: 28192418 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of Preexisting Anti-Hemagglutinin Stalk Antibody as a Correlate of Protection in a Healthy Volunteer Challenge with Influenza A/H1N1pdm Virus. Park JK; Han A; Czajkowski L; Reed S; Athota R; Bristol T; Rosas LA; Cervantes-Medina A; Taubenberger JK; Memoli MJ mBio; 2018 Jan; 9(1):. PubMed ID: 29362240 [TBL] [Abstract][Full Text] [Related]
6. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R mBio; 2017 Sep; 8(5):. PubMed ID: 28928215 [TBL] [Abstract][Full Text] [Related]
7. Kinetics, Longevity, and Cross-Reactivity of Antineuraminidase Antibody after Natural Infection with Influenza A Viruses. Changsom D; Jiang L; Lerdsamran H; Iamsirithaworn S; Kitphati R; Pooruk P; Auewarakul P; Puthavathana P Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29021304 [TBL] [Abstract][Full Text] [Related]
8. Structure-Based Modification of an Anti-neuraminidase Human Antibody Restores Protection Efficacy against the Drifted Influenza Virus. Jiang H; Peng W; Qi J; Chai Y; Song H; Bi Y; Rijal P; Wang H; Oladejo BO; Liu J; Shi Y; Gao GF; Townsend AR; Wu Y mBio; 2020 Oct; 11(5):. PubMed ID: 33024040 [TBL] [Abstract][Full Text] [Related]
9. Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults. Powers DC; Kilbourne ED; Johansson BE Clin Diagn Lab Immunol; 1996 Sep; 3(5):511-6. PubMed ID: 8877127 [TBL] [Abstract][Full Text] [Related]
10. Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza. Job ER; Schotsaert M; Ibañez LI; Smet A; Ysenbaert T; Roose K; Dai M; de Haan CAM; Kleanthous H; Vogel TU; Saelens X J Virol; 2018 Feb; 92(4):. PubMed ID: 29167342 [TBL] [Abstract][Full Text] [Related]
11. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype. Walz L; Kays SK; Zimmer G; von Messling V J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654 [TBL] [Abstract][Full Text] [Related]
12. Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice. Wohlbold TJ; Nachbagauer R; Xu H; Tan GS; Hirsh A; Brokstad KA; Cox RJ; Palese P; Krammer F mBio; 2015 Mar; 6(2):e02556. PubMed ID: 25759506 [TBL] [Abstract][Full Text] [Related]
13. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge. Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689 [TBL] [Abstract][Full Text] [Related]
14. Comparability of neuraminidase inhibition antibody titers measured by enzyme-linked lectin assay (ELLA) for the analysis of influenza vaccine immunogenicity. Eichelberger MC; Couzens L; Gao Y; Levine M; Katz J; Wagner R; Thompson CI; Höschler K; Laurie K; Bai T; Engelhardt OG; ; Wood J Vaccine; 2016 Jan; 34(4):458-465. PubMed ID: 26707221 [TBL] [Abstract][Full Text] [Related]